GHRP-2, GHRP-6, and hexarelin are synthetic growth-hormone-releasing peptides (GHRPs)—six-amino-acid secretagogues that bind the ghrelin receptor (GHSR-1a) and trigger a pulse of GH release from the pituitary. None of them has FDA approval for human use, and WADA prohibits all three as GH secretagogues under prohibited-list category S2. Gray-market vials marketed as “research use only” sit outside any supervised prescriber pathway.

Safety note. This article is educational and for personal recordkeeping only. It gives no dose, unit count, concentration, reconstitution, injection technique, vendor, cycle, or stacking instructions. Peptide decisions, especially gray-market or research-use products, belong with a licensed professional.

What is GHRP-2, GHRP-6, and hexarelin?

GHRPs are a family of synthetic hexapeptides designed to mimic the GH-releasing effect of ghrelin, the gut-derived “hunger hormone.” GHRP-2 gives a relatively clean GH pulse with modest appetite stimulation; GHRP-6 stimulates a stronger appetite response alongside GH release; hexarelin generates the largest GH pulse of the three but also carries a known desensitization profile with repeated use. All three were developed as research tools and none progressed to FDA approval for any human indication.

The three are often stacked together or paired with a GHRH analog (like CJC-1295) in community discussions, and vendor posts treat them as interchangeable. Their differing receptor profiles and appetite or desensitization effects mean they are not interchangeable—and the absence of a legal human-use pathway means the people equipped to supervise them are medical professionals who understand that distinction. For a broader safety frame, read Research Peptide Safety Questions Before You Start.

What do people use GHRP-2, GHRP-6, and hexarelin for?

People most often mention GHRP-2, GHRP-6, and hexarelin for appetite, muscle gain, sleep, recovery, body composition, and older bodybuilding peptide stacks. Those are community claims, not proof. The same claim can mean very different things depending on whether it comes from a clinical label, a small trial, an animal model, a vendor page, or a forum anecdote.

Use the claim as a filing label, not a conclusion. Write down the purpose in plain language: what outcome is being watched, what else changed at the same time, and what would count as a reason to stop and ask for care.

How do people discuss using GHRP-2, GHRP-6, and hexarelin?

Reported use usually means research-use products, bodybuilding forums, and comparisons with ipamorelin, CJC-1295, sermorelin, or MK-677. The useful part to record is context, not numbers: why it was considered, who reviewed it, what else was already in the stack, and what stop signs were discussed.

Do not copy online calculators, vendor protocols, or preparation walkthroughs into a personal plan. A peptide protocol log should preserve professional guidance and observations, not turn a social post into instructions.

What does the research say?

FDA safety material flags GHRP-2 and GHRP-6 concerns in compounding contexts, and WADA lists growth hormone secretagogues and related mimetics as prohibited.

A good research note separates mechanism, animal data, human trial data, approval status, and real-world anecdotes. When those buckets get mixed together, a peptide can look more proven than it is.

What should a beginner track?

Track appetite, sleep, glucose concerns, swelling, mood, training load, clinician comments, and whether a sport or testing policy applies.

In Dosefi, keep the entry boring and complete: date, category, source type, professional guidance, symptoms, photos only when useful, and the question you want answered next. A clear log is not proof that the peptide works. It is a way to avoid rewriting the story after the fact.

What red flags matter most?

Appetite, blood sugar, cortisol, prolactin, edema, and heart concerns are not minor details. Older forum protocols often ignore the monitoring that hormone-active substances require.

Also pause when a product is sold only through anonymous vendors, when a blend hides individual ingredients, when the seller offers medical claims without medical oversight, or when the only evidence is a before-and-after post. Serious symptoms should be handled as health events, not as content to troubleshoot in comments.

Sources